Lipocine CFO Morgan Brown resigns effective Jan 31; Krista Fogarty appointed Principal Accounting Officer

Lipocine Inc.

Morgan Brown resigns as EVP and CFO, effective Jan 31, 2022; no disagreement with company.
CEO Mahesh Patel will serve as interim Principal Financial Officer until successor is appointed.
Krista Fogarty, Corporate Controller, appointed Principal Accounting Officer effective Jan 19, 2022.
Fogarty has prior CFO and controller experience at biotech and pharma companies including NPS Pharmaceuticals.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Morgan Brown

Executive Vice President and Chief Financial Officer

LPCN · Lipocine Inc.

Effective: 2022-01-31
Successor: Mahesh Patel
Filed: January 21, 2022, 6:59 PM ET

On January 17, 2022, Morgan Brown provided Lipocine, Inc. (the “Company”) with notice of his intent to resign from his position as Executive Vice President and Chief Financial Officer of the Company, effective as of January 31, 2022.

Role change (interim)

Mahesh Patel

Principal Financial Officer

LPCN · Lipocine Inc.

Effective: 2022-01-31
Filed: January 21, 2022, 6:59 PM ET

Upon the effective date of Mr. Brown’s resignation, Mahesh Patel, the Company’s President and Chief Executive Officer, will serve as the Company’s Principal Financial Officer on an interim basis until Mr. Brown’s successor is appointed.

Appointed

Krista Fogarty

Principal Accounting Officer

LPCN · Lipocine Inc.

Effective: 2022-01-19
Filed: January 21, 2022, 6:59 PM ET

On January 19, 2022, the Board of Directors of the Company appointed Krista Fogarty, the Company’s Corporate Controller, to also serve as the Principal Accounting Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Morgan Brown resigned as Executive Vice President and Chief Financial Officer at Lipocine Inc..

Action: resigned
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On January 17, 2022, Morgan Brown provided Lipocine, Inc. (the “Company”) with notice of his intent to resign from his position as Executive Vice President and Chief Financial Officer of the Company, effective as of January 31, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Mahesh Patel changed role as Principal Financial Officer at Lipocine Inc..

Action: will serve as
Role: Principal Financial Officer

Exact text from the filing

Upon the effective date of Mr. Brown’s resignation, Mahesh Patel, the Company’s President and Chief Executive Officer, will serve as the Company’s Principal Financial Officer on an interim basis until Mr. Brown’s successor is appointed.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Krista Fogarty was appointed as Principal Accounting Officer at Lipocine Inc..

Action: appointed
Role: Principal Accounting Officer

Exact text from the filing

On January 19, 2022, the Board of Directors of the Company appointed Krista Fogarty, the Company’s Corporate Controller, to also serve as the Principal Accounting Officer of the Company.

View on SEC.gov

Lipocine Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-001941

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.